Free Trial

Milestone Pharmaceuticals (MIST) SEC Filings & 10K Form

Milestone Pharmaceuticals logo
$1.58 +0.01 (+0.64%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$1.56 -0.02 (-0.95%)
As of 07/25/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Milestone Pharmaceuticals SEC Filings

DateFilerForm TypeView
07/14/2025
6:30 AM
Milestone Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2025
5:02 AM
Milestone Pharmaceuticals (Filer)
Form 424B5
07/11/2025
5:49 AM
Milestone Pharmaceuticals (Filer)
Form 424B5
07/11/2025
5:12 AM
Milestone Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2025
7:06 AM
Milestone Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
6:00 AM
Milestone Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2025
6:11 AM
Milestone Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2025
4:01 PM
Milestone Pharmaceuticals (Filer)
Form DEF 14A
04/30/2025
4:02 PM
Milestone Pharmaceuticals (Filer)
Form DEFA14A
04/22/2025
8:32 AM
BlackRock, Inc. (Filed by)
Milestone Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
03/28/2025
6:05 AM
Milestone Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2025
4:04 PM
Milestone Pharmaceuticals (Filer)
Form 424B5
03/13/2025
6:28 AM
Milestone Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/13/2025
6:04 AM
Milestone Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/13/2025
6:18 AM
Milestone Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
8:00 AM
Milestone Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SCHEDULE 13G/A
01/29/2025
3:15 PM
Milestone Pharmaceuticals (Issuer)
Oliveto Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
3:15 PM
Bharucha David (Reporting)
Milestone Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
3:15 PM
Milestone Pharmaceuticals (Issuer)
Muller Lorenz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
3:15 PM
Hasija Amit (Reporting)
Milestone Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
3:15 PM
Milestone Pharmaceuticals (Issuer)
Nelson Jeffrey Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2024
11:15 PM
Milestone Pharmaceuticals (Filer)
Form EFFECT
11/12/2024
6:02 AM
Milestone Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/29/2024
3:30 PM
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Milestone Pharmaceuticals (Subject)
Form SC 13G/A
09/05/2024
3:30 PM
Milestone Pharmaceuticals (Issuer)
PAPA JOSEPH C (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/05/2024
3:31 PM
Milestone Pharmaceuticals (Issuer)
PAPA JOSEPH C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
7:07 AM
Milestone Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2024
3:15 PM
Milestone Pharmaceuticals (Issuer)
Wills Robert James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
3:15 PM
Milestone Pharmaceuticals (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
3:15 PM
Fischer Seth H. Z. (Reporting)
Milestone Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
3:15 PM
Giles Lisa M. (Reporting)
Milestone Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
3:15 PM
Duty Stuart (Reporting)
Milestone Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
3:15 PM
Milestone Pharmaceuticals (Issuer)
Saik Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
3:28 PM
Milestone Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MIST) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners